View More
In this Interactive Virtual Presentation, gain case-based insights in incorporating new findings and novel agents into the treatment paradigm for patients with multiple myeloma.
Peter M. Voorhees, MD
Physicians:
maximum of 2.0 AMA PRA Category 1 Credits™
Released: June 23, 2020
Expired: June 22, 2021
Download this slideset from Peter M. Voorhees, MD, on optimal management approaches for patients with multiple myeloma.
Peter M. Voorhees, MD
Released: June 23, 2020
Are you up to date on the latest information on frontline induction, consolidation, and maintenance regimens for patients with newly diagnosed myeloma?
Elisabet E. Manasanch, MD
Released: August 9, 2019
New approaches promise to transform care in multiple myeloma again. Read my thoughts on the most promising novel agents in clinical trial!
Sarah A. Holstein, MD, PhD
Released: October 30, 2019
Gain practical insights for your care of patients with relapsed/refractory myeloma
Elisabet E. Manasanch, MD
Released: January 31, 2020
Suzanne Lentzsch, MD, PhD, talks about her experiences with COVID-19 as she cares for patients with myeloma.
Suzanne Lentzsch, MD, PhD
Released: April 28, 2020
Download this 2019 treatment algorithm that includes a list of key ongoing or enrolling clinical trials to help select optimal treatment options for your patients with myeloma.
Ajai Chari, MD
Released: August 22, 2019
Download this slideset on a multidisciplinary perspective on optimal management approaches for patients with multiple myeloma.
Charise Gleason, MSN, NP-BC, AOCNP
Sagar Lonial, MD
Kathryn Maples, PharmD, BCOP
Released: May 1, 2020
Use this Interactive Decision Support Tool to compare your choice of therapy for patients with myeloma with those of 5 internationally recognized myeloma experts.
Sarah A. Holstein, MD, PhD
Carol Ann Huff, MD
Shaji Kumar, MD
Sagar Lonial, MD
Peter M. Voorhees, MD
Released: April 10, 2020
Get multidisciplinary insights on the latest treatment strategies for multiple myeloma including advances across the disease spectrum, from smoldering myeloma to relapsed/refractory disease.
Charise Gleason, MSN, NP-BC, AOCNP
Sagar Lonial, MD
Kathryn Maples, PharmD, BCOP
Physicians:
maximum of 1.0 AMA PRA Category 1 Credit™
Registered Nurses:
1.0 Nursing contact hour
Pharmacists:
1.0 contact hour (0.1 CEUs)
Released: May 1, 2020
Expired: April 30, 2021
Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270
Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.